Approval · Notice of Compliance 22255 · 2019
BOTOX: Notice of Compliance 22255
Issued June 7, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22255
- Date
- June 7, 2019
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOTOX | Not yet assigned | — |
Medicinal ingredients
- ONABOTULINUMTOXINA 100 UNIT per VIAL
- ONABOTULINUMTOXINA 50 UNIT per VIAL
- ONABOTULINUMTOXINA 200 UNIT per VIAL